Age-related differences in susceptibility to cisplatin-induced renal toxicity

Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied toxicology 2010-03, Vol.30 (2), p.172-182
Hauptverfasser: Espandiari, P., Rosenzweig, B., Zhang, J., Zhou, Y., Schnackenberg, L., Vaidya, V. S., Goering, P. L., Brown, R. P., Bonventre, J. V., Mahjoob, K., Holland, R. D., Beger, R. D., Thompson, K., Hanig, J., Sadrieh, N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 182
container_issue 2
container_start_page 172
container_title Journal of applied toxicology
container_volume 30
creator Espandiari, P.
Rosenzweig, B.
Zhang, J.
Zhou, Y.
Schnackenberg, L.
Vaidya, V. S.
Goering, P. L.
Brown, R. P.
Bonventre, J. V.
Mahjoob, K.
Holland, R. D.
Beger, R. D.
Thompson, K.
Hanig, J.
Sadrieh, N.
description Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day‐old vs 10 ≥ 80 > 40 > 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley & Sons, Ltd. Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).
doi_str_mv 10.1002/jat.1484
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2829343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>883022783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhS0EotOCxC9A2SC6SbGv49cGaTSCFlQeiyJQN5bj2MXFkwx2Ap1_j0cTDbBAYuXF-XzOvfcg9ITgM4IxvLg14xlpZHMPLQhWqibA6X20wMBx3VDx5Qgd53yLcdFAPkRHREmqirpA75Y3rk4umtF1VRe8d8n11uUq9FWesnWbMbQhhnFbjUNlQ94UNPR16LvJli-FNrFId8EW5hF64E3M7vH8nqBPr19drS7qyw_nb1bLy9pyLJoaWEkXoJwwgkrqWQdtZxQmzHWeCcC2dbgRtrEWjFGyaSUva1KirGfcE3qCXu59N1O7dp11_ZhM1JsU1iZt9WCC_lvpw1d9M_zQIEHRhhaD57NBGr5PLo96HcqyMZreDVPWUlIMIOR_kFwxyYBDIU_3pE1Dzsn5wzwE611NutSkdzUV9Omf8_8G514K8GwGTLYm-mT6cvsDB9CAYHxnVO-5nyG67T8D9dvl1Rw88yGP7u7Am_RNc0EF05_fn-uL1TX-eA1cM_oL_pC40w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>869585262</pqid></control><display><type>article</type><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</creator><creatorcontrib>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</creatorcontrib><description>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 &gt; 40 &gt; 10 &gt; 25 day‐old vs 10 ≥ 80 &gt; 40 &gt; 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley &amp; Sons, Ltd. Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</description><identifier>ISSN: 0260-437X</identifier><identifier>ISSN: 1099-1263</identifier><identifier>EISSN: 1099-1263</identifier><identifier>DOI: 10.1002/jat.1484</identifier><identifier>PMID: 19839026</identifier><identifier>CODEN: JJATDK</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Age Factors ; age-related nephrotoxicity ; Aging - physiology ; Animals ; Biological and medical sciences ; biomarkers ; Biomarkers - metabolism ; Biomarkers - urine ; Child ; cisplatin ; Cisplatin - toxicity ; Disease Susceptibility - metabolism ; Disease Susceptibility - pathology ; Drug toxicity and drugs side effects treatment ; Gentamicins - toxicity ; Humans ; Kidney - metabolism ; Kidney - pathology ; Kidney Diseases - chemically induced ; Kidney Diseases - pathology ; Kidney Diseases - urine ; Kim-1 ; Medical sciences ; metabonomics ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Models, Animal ; Pediatrics ; Pharmacology. Drug treatments ; Rats ; Rats, Sprague-Dawley ; Sensitivity and Specificity</subject><ispartof>Journal of applied toxicology, 2010-03, Vol.30 (2), p.172-182</ispartof><rights>Copyright © 2009 John Wiley &amp; Sons, Ltd.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</citedby><cites>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjat.1484$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjat.1484$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22427564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19839026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Espandiari, P.</creatorcontrib><creatorcontrib>Rosenzweig, B.</creatorcontrib><creatorcontrib>Zhang, J.</creatorcontrib><creatorcontrib>Zhou, Y.</creatorcontrib><creatorcontrib>Schnackenberg, L.</creatorcontrib><creatorcontrib>Vaidya, V. S.</creatorcontrib><creatorcontrib>Goering, P. L.</creatorcontrib><creatorcontrib>Brown, R. P.</creatorcontrib><creatorcontrib>Bonventre, J. V.</creatorcontrib><creatorcontrib>Mahjoob, K.</creatorcontrib><creatorcontrib>Holland, R. D.</creatorcontrib><creatorcontrib>Beger, R. D.</creatorcontrib><creatorcontrib>Thompson, K.</creatorcontrib><creatorcontrib>Hanig, J.</creatorcontrib><creatorcontrib>Sadrieh, N.</creatorcontrib><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><title>Journal of applied toxicology</title><addtitle>J. Appl. Toxicol</addtitle><description>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 &gt; 40 &gt; 10 &gt; 25 day‐old vs 10 ≥ 80 &gt; 40 &gt; 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley &amp; Sons, Ltd. Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</description><subject>Age Factors</subject><subject>age-related nephrotoxicity</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Biomarkers - urine</subject><subject>Child</subject><subject>cisplatin</subject><subject>Cisplatin - toxicity</subject><subject>Disease Susceptibility - metabolism</subject><subject>Disease Susceptibility - pathology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Gentamicins - toxicity</subject><subject>Humans</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney Diseases - urine</subject><subject>Kim-1</subject><subject>Medical sciences</subject><subject>metabonomics</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Models, Animal</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensitivity and Specificity</subject><issn>0260-437X</issn><issn>1099-1263</issn><issn>1099-1263</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUhS0EotOCxC9A2SC6SbGv49cGaTSCFlQeiyJQN5bj2MXFkwx2Ap1_j0cTDbBAYuXF-XzOvfcg9ITgM4IxvLg14xlpZHMPLQhWqibA6X20wMBx3VDx5Qgd53yLcdFAPkRHREmqirpA75Y3rk4umtF1VRe8d8n11uUq9FWesnWbMbQhhnFbjUNlQ94UNPR16LvJli-FNrFId8EW5hF64E3M7vH8nqBPr19drS7qyw_nb1bLy9pyLJoaWEkXoJwwgkrqWQdtZxQmzHWeCcC2dbgRtrEWjFGyaSUva1KirGfcE3qCXu59N1O7dp11_ZhM1JsU1iZt9WCC_lvpw1d9M_zQIEHRhhaD57NBGr5PLo96HcqyMZreDVPWUlIMIOR_kFwxyYBDIU_3pE1Dzsn5wzwE611NutSkdzUV9Omf8_8G514K8GwGTLYm-mT6cvsDB9CAYHxnVO-5nyG67T8D9dvl1Rw88yGP7u7Am_RNc0EF05_fn-uL1TX-eA1cM_oL_pC40w</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Espandiari, P.</creator><creator>Rosenzweig, B.</creator><creator>Zhang, J.</creator><creator>Zhou, Y.</creator><creator>Schnackenberg, L.</creator><creator>Vaidya, V. S.</creator><creator>Goering, P. L.</creator><creator>Brown, R. P.</creator><creator>Bonventre, J. V.</creator><creator>Mahjoob, K.</creator><creator>Holland, R. D.</creator><creator>Beger, R. D.</creator><creator>Thompson, K.</creator><creator>Hanig, J.</creator><creator>Sadrieh, N.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope><scope>5PM</scope></search><sort><creationdate>201003</creationdate><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><author>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Age Factors</topic><topic>age-related nephrotoxicity</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Biomarkers - urine</topic><topic>Child</topic><topic>cisplatin</topic><topic>Cisplatin - toxicity</topic><topic>Disease Susceptibility - metabolism</topic><topic>Disease Susceptibility - pathology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Gentamicins - toxicity</topic><topic>Humans</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney Diseases - urine</topic><topic>Kim-1</topic><topic>Medical sciences</topic><topic>metabonomics</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Models, Animal</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espandiari, P.</creatorcontrib><creatorcontrib>Rosenzweig, B.</creatorcontrib><creatorcontrib>Zhang, J.</creatorcontrib><creatorcontrib>Zhou, Y.</creatorcontrib><creatorcontrib>Schnackenberg, L.</creatorcontrib><creatorcontrib>Vaidya, V. S.</creatorcontrib><creatorcontrib>Goering, P. L.</creatorcontrib><creatorcontrib>Brown, R. P.</creatorcontrib><creatorcontrib>Bonventre, J. V.</creatorcontrib><creatorcontrib>Mahjoob, K.</creatorcontrib><creatorcontrib>Holland, R. D.</creatorcontrib><creatorcontrib>Beger, R. D.</creatorcontrib><creatorcontrib>Thompson, K.</creatorcontrib><creatorcontrib>Hanig, J.</creatorcontrib><creatorcontrib>Sadrieh, N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of applied toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espandiari, P.</au><au>Rosenzweig, B.</au><au>Zhang, J.</au><au>Zhou, Y.</au><au>Schnackenberg, L.</au><au>Vaidya, V. S.</au><au>Goering, P. L.</au><au>Brown, R. P.</au><au>Bonventre, J. V.</au><au>Mahjoob, K.</au><au>Holland, R. D.</au><au>Beger, R. D.</au><au>Thompson, K.</au><au>Hanig, J.</au><au>Sadrieh, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age-related differences in susceptibility to cisplatin-induced renal toxicity</atitle><jtitle>Journal of applied toxicology</jtitle><addtitle>J. Appl. Toxicol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>30</volume><issue>2</issue><spage>172</spage><epage>182</epage><pages>172-182</pages><issn>0260-437X</issn><issn>1099-1263</issn><eissn>1099-1263</eissn><coden>JJATDK</coden><abstract>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 &gt; 40 &gt; 10 &gt; 25 day‐old vs 10 ≥ 80 &gt; 40 &gt; 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley &amp; Sons, Ltd. Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>19839026</pmid><doi>10.1002/jat.1484</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0260-437X
ispartof Journal of applied toxicology, 2010-03, Vol.30 (2), p.172-182
issn 0260-437X
1099-1263
1099-1263
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2829343
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Age Factors
age-related nephrotoxicity
Aging - physiology
Animals
Biological and medical sciences
biomarkers
Biomarkers - metabolism
Biomarkers - urine
Child
cisplatin
Cisplatin - toxicity
Disease Susceptibility - metabolism
Disease Susceptibility - pathology
Drug toxicity and drugs side effects treatment
Gentamicins - toxicity
Humans
Kidney - metabolism
Kidney - pathology
Kidney Diseases - chemically induced
Kidney Diseases - pathology
Kidney Diseases - urine
Kim-1
Medical sciences
metabonomics
Miscellaneous (drug allergy, mutagens, teratogens...)
Models, Animal
Pediatrics
Pharmacology. Drug treatments
Rats
Rats, Sprague-Dawley
Sensitivity and Specificity
title Age-related differences in susceptibility to cisplatin-induced renal toxicity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A34%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age-related%20differences%20in%20susceptibility%20to%20cisplatin-induced%20renal%20toxicity&rft.jtitle=Journal%20of%20applied%20toxicology&rft.au=Espandiari,%20P.&rft.date=2010-03&rft.volume=30&rft.issue=2&rft.spage=172&rft.epage=182&rft.pages=172-182&rft.issn=0260-437X&rft.eissn=1099-1263&rft.coden=JJATDK&rft_id=info:doi/10.1002/jat.1484&rft_dat=%3Cproquest_pubme%3E883022783%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=869585262&rft_id=info:pmid/19839026&rfr_iscdi=true